Cardiovascular diseases and fat soluble vitamins: Vitamin D and vitamin K

Journal of Nutritional Science and Vitaminology

Volumn 61, Issue , 2015, Pages S170-S172

  Tsugawa, Naoko ^a,b  

^a KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^b OSAKA SHOIN WOMEN'S UNIVERSITY   (Japan)

Author keywords

Cardiovascular disease; Fat soluble vitamins; Mortality; Vitamin D; Vitamin K

Indexed keywords

MENAQUINONE; PARATHYROID HORMONE; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN K GROUP; VITAMIN;

ARTERIAL STIFFNESS; ARTICLE; BONE METABOLISM; CALCIFICATION; CALCIUM METABOLISM; CARDIOVASCULAR DISEASE; FRACTURE; HEART INFARCTION; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; MORTALITY; NONHUMAN; VITAMIN DEFICIENCY; VITAMIN K DEFICIENCY; ANIMAL; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; METABOLISM; NUTRITIONAL STATUS; PATHOLOGY; VASCULAR CALCIFICATION;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; NUTRITIONAL STATUS; VASCULAR CALCIFICATION; VITAMIN D; VITAMIN K; VITAMINS;

EID: 84950318968     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.61.S170     Document Type: Article

References (22)

1. Farhangi MA, Keshavarz SA, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi AA. 2013. Vitamin A supplementation and serum Th1-and Th2-associated cytokine response in women. J Am Coll Nutr 32: 280-285.
2. Vardi M, Levy NS, Levy AP. 2013. Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection. J Lipid Res 54: 2307-2314.
3. Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. 2008. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 102: 1540-1544.
4. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 2008. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 168: 1174-1180.
5. Liew JY, Sasha SR, Ngu PJ, Warren JL, Wark J, Dart AM, Shaw JA. 2014. Circulating vitamin D levels are associated with the presence and severity of coronary artery disease but not peripheral arterial disease in patients undergoing coronary angiography. Nutr Metab Cardiovasc Dis: Epub ahead of print.
6. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. 2008. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117: 503-511.
7. Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W. 2008. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168: 1340-1349.
8. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. 2009. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57: 1595-1603.
9. Khaw KT, Luben R, Wareham N. 2014. Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratorydisease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr 100: 1361-1370.
10. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. 2007. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 49: 1063-1069.
11. Uemura H, Katsuura-Kamano S, Yamaguchi M, Nakamoto M, Hiyoshi M, Arisawa K. 2014. Association between dietary calcium intake and arterial stiffness according to dietary vitamin D intake in men. Br J Nutr 112: 1333-1340.
12. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, März W. 2010. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 411: 1354-1360.
13. 3 on vascular smooth muscle cells. Acta Biochim Pol 59: 395-400.
14. Andrukhova O, Slavic S, Zeitz U, Riesen SC, Heppelmann MS, Ambrisko TD, Markovic M, Kuebler WM, Erben RG. 2014. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol 28: 53-64.
15. 3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol 30: 2495-2503.
16. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 2002. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238.
17. 3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282: 29821-29830.
18. Zebboudj AF, Imura M, Bostrom K. 2002. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277: 4388-4394.
19. Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, van der Schouw YT. 2009. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis 203: 489-493.
20. Keyzer CA, Vermeer C, Joosten MM, Knapen MH, Drummen NE, Navis G, Bakker SJ, de Borst MH. 2014. Vitamin K Status and Mortality After Kidney Transplantation: A Cohort Study. Am J Kidney Dis: Epub ahead of print.
21. Delanaye P, Krzesinski JM, Warling X, Moonen M, Smelten N, Médart L, Pottel H, Cavalier E. 2014. Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients. BMC Nephrol 15: 145-152.
22. Mayer O Jr, Seidlerová J, Bruthans J, Filipovský J, Timoracká K, Vaněk J, Cerná L, Wohlfahrt P, Cífková R, Theuwissen E, Vermeer C. 2014. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease. Atherosclerosis 235: 162-168.